Editorial
doi: 10.1016/j.urology.2009.06.056.
Editorial comment
- PMID: 20211359
- PMCID: PMC2896285
- DOI: 10.1016/j.urology.2009.06.056
Item in Clipboard
Editorial
Editorial comment
Urology.
2010 Mar.
No abstract available
Comment on
-
Reduction in the risk of prostate cancer: future directions after the Prostate Cancer Prevention Trial.Urology. 2010 Mar;75(3):502-9. doi: 10.1016/j.urology.2009.05.099. Epub 2009 Dec 29. Urology. 2010. PMID: 20035983 Review.
Similar articles
-
Editorial comment on: Pharmacological approaches to reducing the risk of prostate cancer.Eur Urol. 2009 May;55(5):1074. doi: 10.1016/j.eururo.2009.01.039. Epub 2009 Feb 5. Eur Urol. 2009. PMID: 19200637 No abstract available.
-
Prostate cancer chemoprevention: more than meets the eye.Can J Urol. 2010 Jun;17(3):5148. Can J Urol. 2010. PMID: 20566004 No abstract available.
-
Chemoprevention of prostate cancer comes of age.BJU Int. 2004 Mar;93(4):459-60. doi: 10.1111/j.1464-410x.2003.04648.x. BJU Int. 2004. PMID: 15008706 No abstract available.
-
[Chemoprevention of prostatic cancer].Prog Urol. 2003 Nov;13(5 Suppl 2):1262-7. Prog Urol. 2003. PMID: 15816402 Review. French. No abstract available.
-
Current and future status of prostate cancer chemoprevention.Expert Rev Anticancer Ther. 2006 Jan;6(1):59-71. doi: 10.1586/14737140.6.1.59. Expert Rev Anticancer Ther. 2006. PMID: 16375645 Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
